Safranal has demonstrated anti-inflammatory effects on OVA-induced airway inflammation via modulation of type 1 and 2 helper T lymphocytes balance, evident from the reduced serum IL-4 and elevated IFNγ (Boskabady et al., 2014). This evidence concerns the gene IL4 and inflammatory response.